Top European Stocks To Watch Amid Tariff Turmoil

6 min read
0 views
Apr 22, 2025

Trump’s tariffs are shaking European stocks. Which companies will weather the storm? Dive into our analysis of 5 key players to watch this earnings season...

Financial market analysis from 22/04/2025. Market conditions may have changed since publication.

Have you ever watched a storm brew on the horizon, knowing it’s about to change everything? That’s the vibe in the European stock market right now, as U.S. President Donald Trump’s sweeping tariffs send shockwaves through global trade. Investors are bracing for a wild ride this earnings season, with uncertainty hanging heavy. I’ve been digging into the chaos, and let me tell you, some companies are poised to weather this better than others. Let’s dive into five European giants you’ll want to keep on your radar as the tariff drama unfolds.

Navigating the Tariff Tempest: Why These Stocks Matter

The tariff landscape is a mess—25% on EU goods, 10% on the UK, and targeted hits on steel, aluminum, and autos. It’s not just the scale; it’s the unpredictability. One day, a policy drops; the next, it’s tweaked or reversed. For European firms, this is a high-stakes game. Global trade is their lifeblood, and with the U.S.-China trade war looming, the stakes couldn’t be higher. These five companies—spanning shipping, energy, automotive, airlines, and pharmaceuticals—are bellwethers for how the market might respond.


Maersk: The Pulse of Global Shipping

If global trade were a living thing, Maersk would be its heartbeat. This Danish shipping titan, reporting earnings on May 8, is a go-to for gauging trade health. Lately, its stock has been on a rollercoaster, spiking and dipping with every tariff headline. Why? Because an escalating U.S.-China trade war could choke the maritime sector, and Maersk’s right in the crosshairs.

The global trade outlook has deteriorated sharply, and tariffs are a significant headwind for stability.

– Trade organization analyst

Analysts are projecting Maersk’s first-quarter EBITDA at $2.3 billion, a drop from $3.6 billion in Q4 2024. That’s not catastrophic, but it’s a red flag. The company’s been candid, calling the tariffs “not good news” for the economy. What’s intriguing, though, is their wait-and-see approach. Will countries negotiate? Slap on counter-tariffs? Maersk’s hedging its bets, and investors are watching closely.

  • Key Concern: U.S.-China trade tensions disrupting shipping routes.
  • Investor Tip: Monitor tariff policy updates for short-term stock swings.
  • Upside Potential: Strategic cost-cutting could cushion the blow.

Shell: Energy Giant in a Volatile World

Shell, the British oil behemoth, is up next, with earnings due May 2. Energy stocks are tricky right now—caught between recession fears, weak oil demand, and tariff-driven market jitters. Shell’s been making bold moves, doubling down on liquefied natural gas (LNG) and promising juicier shareholder returns. But there’s a catch: they can’t control crude prices, and that’s a problem.

In March, Shell trimmed its LNG production outlook due to maintenance issues. Add tariffs to the mix, and you’ve got a recipe for volatility. Analysts expect first-quarter adjusted earnings of $5.14 billion, down from $7.73 billion a year ago. Still, I’m impressed by Shell’s focus on efficiency under CEO Wael Sawan. They’re lean, mean, and ready to grow cash flow—tariffs or no tariffs.

SectorChallengeShell’s Strategy
EnergyFalling oil pricesCost discipline
LNGProduction setbacksLong-term expansion
MarketTariff uncertaintyShareholder focus

What’s my take? Shell’s a survivor. They’ve navigated oil slumps before, and their capital allocation is top-notch. But if oil prices keep sliding, even the best-laid plans might wobble.


Volkswagen: Driving Through Tariff Headwinds

Germany’s automotive titan Volkswagen is set to report on April 30, and tariffs are hitting them where it hurts. A 25% U.S. levy on foreign cars is bad news for a company exporting thousands of vehicles stateside. Sure, their Tennessee plant helps, but many parts still come from Europe. That’s a tariff double-whammy.

We’re an American company in spirit, but tariffs don’t care about sentiment.

– Automotive industry executive

Analysts are cautiously optimistic, forecasting Q1 revenue of €77.6 billion, up from €75.5 billion last year. But EBIT is expected to slip to €4.03 billion from €4.6 billion. Volkswagen’s scrambling to localize more production, but that takes time. For now, expect some turbulence—and maybe some panic-buying of their U.S.-made cars.

Here’s a thought: could tariffs push Volkswagen to innovate faster on electric vehicles? It’s a stretch, but necessity breeds creativity.


Lufthansa: Flying in Geopolitical Winds

Airlines are always a wild card, and Lufthansa’s no exception. Their April 29 earnings could reveal how geopolitical tensions and tariffs are reshaping travel demand. Earlier this year, CEO Carsten Spohr was bullish, predicting strong global demand. But with U.S. tariffs sparking boycotts and a 17.2% drop in Western European visitors to the U.S., that optimism might be tested.

Lufthansa’s already juggling strikes, Boeing delivery delays, and global price pressures. Analysts expect Q1 revenue of €8.07 billion, up from €7.4 billion, but a €630 million EBIT loss. That’s better than last year’s €871 million loss, but it’s no victory lap. What’s fascinating is how tariffs could shift travel patterns—fewer transatlantic flights, maybe more intra-European routes?

  1. Watch Transatlantic Trends: Declining U.S. visitors could hit profits.
  2. Diversify Routes: Lufthansa might pivot to Asia or Middle East markets.
  3. Cost Control: Expect tighter budgets to offset tariff impacts.

Personally, I’m curious if Lufthansa can turn this into an opportunity. Maybe they’ll lean into regional travel or premium services to offset losses. It’s a long shot, but airlines are nothing if not adaptable.


Novo Nordisk: Pharma’s Tariff Tightrope

Denmark’s Novo Nordisk, a pharma powerhouse, is walking a tightrope. Their May 7 earnings will shed light on how tariffs might hit their U.S. sales of Ozempic and Wegovy, two blockbuster drugs for diabetes and obesity. The Trump administration’s talk of drug tariffs—framed as a national security probe—has investors on edge.

Tariffs are the top worry for investors right now. No one knows what’s coming.

– European pharmaceuticals analyst

Novo’s got a strong U.S. manufacturing presence, which could soften the blow. But with no clarity on tariff size or timing, it’s a guessing game. What’s clear is their market dominance—Wegovy’s demand is through the roof. If they can navigate this, they might come out stronger. But that’s a big “if.”

I can’t help but wonder: could tariffs force Novo to rethink pricing or accelerate local production? It’s a headache, but they’ve got the cash to pivot.


What’s Next for Investors?

So, where does this leave us? The tariff storm is far from over, and these five companies—Maersk, Shell, Volkswagen, Lufthansa, and Novo Nordisk—are at the heart of it. Each faces unique challenges, from trade route disruptions to shifting consumer behavior. But they also have strengths: diversified operations, strong leadership, and, in some cases, a knack for turning chaos into opportunity.

Here’s my two cents: don’t panic. Markets hate uncertainty, but they also reward those who stay sharp. Keep an eye on earnings reports, watch for policy shifts, and don’t underestimate these companies’ ability to adapt. After all, they’ve survived storms before.

In times of turmoil, the best investors don’t just react—they anticipate.

As we head deeper into earnings season, one thing’s certain: the tariff saga will keep us on our toes. Which of these stocks are you betting on? And what’s your strategy for navigating this wild market? I’m all ears.

Investor Checklist:
  Monitor tariff policy updates daily.
  Analyze earnings for tariff impact clues.
  Diversify to hedge against volatility.

This earnings season is a crucible for European stocks. The companies that emerge stronger will be the ones that adapt fastest. Stay tuned, stay informed, and maybe—just maybe—you’ll spot the next big opportunity amid the chaos.

Success is walking from failure to failure with no loss of enthusiasm.
— Winston Churchill
Author

Steven Soarez passionately shares his financial expertise to help everyone better understand and master investing. Contact us for collaboration opportunities or sponsored article inquiries.

Related Articles